- Home
- LFST
as 11-18-2025 3:39pm EST
LifeStance Health Group Inc is a mental healthcare company that operates as a provider of outpatient mental health services, spanning psychiatric evaluations and treatment, psychological and neuropsychological testing, and individual, family and group therapy. The group y has a single operating and reportable segment of mental health services.
| Founded: | 2015 | Country: | United States |
| Employees: | N/A | City: | SCOTTSDALE |
| Market Cap: | 1.9B | IPO Year: | 2021 |
| Target Price: | $9.00 | AVG Volume (30 days): | 2.2M |
| Analyst Decision: | Strong Buy | Number of Analysts: | 6 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.03 | EPS Growth: | N/A |
| 52 Week Low/High: | $3.74 - $8.29 | Next Earning Date: | 11-06-2025 |
| Revenue: | $1,367,570,000 | Revenue Growth: | 13.39% |
| Revenue Growth (this year): | 15.35% | Revenue Growth (next year): | 14.14% |
Latest LifeStance Health Group Inc. News
LFST Breaking Stock News: Dive into LFST Ticker-Specific Updates for Smart Investing
MT Newswires
13 days ago
Lifestance Health Group Post Q3 Breakeven, Revenue Rises; Maintains 2025 Revenue Guidance
Zacks
13 days ago
LifeStance Health Group (LFST) Reports Break-Even Earnings for Q3
StockStory
13 days ago
LifeStance Health Group’s (NASDAQ:LFST) Q3 Sales Top Estimates
GlobeNewswire
13 days ago
LifeStance Reports Third Quarter 2025 Results
PR Newswire
14 days ago
Nearly 7 in 10 Americans Feel Pressure to Appear Happier Than They Are This Holiday Season
GuruFocus.com
14 days ago
What To Expect From LifeStance Health Group Inc (LFST) Q3 2025 Earnings
StockStory
14 days ago
LifeStance Health Group (LFST) Reports Q3: Everything You Need To Know Ahead Of Earnings
GlobeNewswire
a month ago
LifeStance to Host Third Quarter 2025 Earnings Conference Call on November 6, 2025
Compare LFST vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "LFST LifeStance Health Group Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.